Targeting the PD-1 Pathway in MSI-Stable Metastatic Colorectal Cancer

Chemotherapy: Open Access
doi 10.4172/2167-7700.1000e132
Full Text
Abstract

Available in full text

Date
Authors
Publisher

OMICS Publishing Group

Related search

New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway

Clinical Cancer Research
Cancer ResearchOncology
2011English

Targeting Metastatic Colorectal Cancer &Ndash; Present and Emerging Treatment Options

Pharmacogenomics and Personalized Medicine
Molecular MedicinePharmacology
2014English

KY1022, a Small Molecule Destabilizing Ras via Targeting the WNT/β-Catenin Pathway, Inhibits Development of Metastatic Colorectal Cancer

Oncotarget
Oncology
2016English

Targeting the PD-1 Pathway: A Promising Future for the Treatment of Melanoma

Archives of Dermatological Research
DermatologyMedicine
2014English

Immunotherapies Based on PD-1/PD-L1 Pathway Inhibitors in Ovarian Cancer Treatment

Clinical and Experimental Immunology
AllergyImmunology
2019English

Immunodivergence in Metastatic Colorectal Cancer

Cancer Cell
Cancer ResearchOncologyCell Biology
2018English

Targeting the ERK Pathway Reduces Liver Metastasis of Smad4-Inactivated Colorectal Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2013English

Direct Therapeutic Targeting of Immune Checkpoint PD-1 in Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Does Sex of the Patient Play a Role in Survival for MSI Colorectal Cancer?

Journal of Mind and Medical Sciences
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy